Effect of Hijamah (wet cupping)in management of cervical spondylosis

Phase 2

• Conditions: Health Condition 1: null- CERVICAL SPONDYLOSIS

• Registration Number: CTRI/2017/08/009384
• Lead Sponsor: JAMIA HAMDARD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Age: 30 to 65 yrs.

Sex: All genders

Patients with signs and symptoms of cervical spondylosis(with or without radicular symptoms) AND radiological changes suggestive of the disease

Patients, who will be willing to discontinue all NSAIDs or other analgesic medication taken for any condition

Willing to sign the informed consent, follow the protocol and participate in clinical trial voluntarily

Exclusion Criteria

Below 30 and above 65 yrs.

Other Diseases of cervical spine like Ankylosing spondylitis, arthritis of neck (except osteoarthritis),Vascular lesions and Neoplasms

Trauma of neck, wry neck (Torticollis), Cervical rib syndrome

Local wound and infection over neck

Spinal cord disorders

Carpal tunnel syndrome

Anemia (Hb < 8gm %)

Preg¬nancy and lactation(6 months post-delivery)

Bleeding Disorders, Patients on anticoagulant treatment / disseminated intravascular coagulation

Patients with systemic disorders like chronic liver, kidney or heart disease

Patients of uncontrolled diabetes mellitus

Terminally ill patients

Patients taking any other type of medicinal (NSAIDs, corticosteroid etc) and non-medicinal treatment for cervical spondylosis

Unwilling patients

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS <br/ ><br>NDI <br/ ><br>SF12 <br/ ><br>CROM <br/ ><br>SIGN AND SYMPTOMSTimepoint: 0 day, 14th day, 21st day and 42nd day

Secondary Outcome Measures

Name	Time	Method
CBCTimepoint: DAY 0, DAY 42